NetworkNewsBreaks

WednesdayDec 03, 2025 10:15 am

NetworkNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Featured in BioMedWire Editorial Highlighting HyBryte(TM) and Rare Disease Policy

Soligenix (NASDAQ: SNGX) was featured in a BioMedWire editorial titled “Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now,” which examines the growing burden of rare diseases affecting more than 30 million Americans and the urgent need for new therapies. The article spotlights Soligenix’s late-stage development of HyBryte(TM) (synthetic hypericin) for cutaneous T-cell lymphoma, now in its final confirmatory study before worldwide marketing submissions, and places the Company’s efforts at the intersection of advancing treatment options and emerging national health policy initiatives. To view the full press release, visit https://nnw.fm/HWgSY About Soligenix Soligenix is a…

Continue Reading

WednesdayDec 03, 2025 9:53 am

NetworkNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Forms U.S. Government Business Unit Led by Jack Sears Jr.

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”) formed a new business unit dedicated to driving the adoption of its quantum computing products and services within the U.S. government. Led by seasoned government and public sector business executive Jack Sears Jr., the newly established unit will support D-Wave’s enterprise-wide U.S. government-related initiative. Sears will join D-Wave’s executive team and serve as the business unit’s vice president of U.S. government solutions. In his role, Sears will oversee government-related go-to-market efforts and application development as well as the unique product development and customer support necessary for secure systems that meet federal requirements. He brings…

Continue Reading

WednesdayDec 03, 2025 9:25 am

NetworkNewsBreaks – Search Minerals Inc. (TSX.V: SMY) (OTC: SHCMF) Settles $404K Debt Through Shares-for-Debt Transaction

This article has been disseminated on behalf of Search Minerals Inc. (TSX.V: SMY) (OTC: SHCMF) and may include paid advertising. Search Minerals (TSX.V: SMY) (OTC: SHCMF) said it entered a transaction with LeadFX Inc. to settle $404,053.73 of outstanding debt through the issuance of 808,107 common shares at a deemed price of $0.50 per share. The Company said completing the Shares-for-Debt transaction, rather than proceeding with a previously planned unsecured convertible loan, will preserve cash and strengthen its balance sheet. The shares will carry a four-month-and-one-day statutory hold period. Because LeadFX is a related party, the transaction falls under MI…

Continue Reading

WednesdayDec 03, 2025 9:15 am

NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Amends IND to Advance NRX-101 With TMS for Depression Treatment

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, said it amended its Investigational New Drug filing for NRX-101 to include use of the drug in combination with Transcranial Magnetic Stimulation for depression, including suicidal depression. The update follows evidence suggesting NRX-101 may significantly enhance TMS outcomes, with published studies showing more than two-fold improvements in symptom reduction and clinical response rates exceeding 80%. The Company noted NRX-101’s D-cycloserine component appears to augment neuroplasticity associated with TMS, while its low-dose lurasidone is intended to mitigate D-cycloserine’s known risk of low-grade hallucinations. NRx said it aims to validate the findings in a…

Continue Reading

TuesdayDec 02, 2025 11:45 am

NetworkNewsBreaks – Massimo Group (NASDAQ: MAMO) Adopts Bitcoin Treasury Strategy With Initial Purchases Underway 

Massimo Group (NASDAQ: MAMO) said its Board approved adding Bitcoin as part of a long-term treasury reserve strategy, with initial purchases already begun and holdings to be disclosed in upcoming SEC filings or via Form 8-K. The Company said the program will be funded primarily through operating cash flows, with the option to use market instruments, and will employ institutional-grade custody with multi-signature cold storage and audit-ready controls. Massimo expects Bitcoin to represent a single-digit percentage of total assets over five years, positioning it as a strategic reserve rather than an operating asset. CEO David Shan said the move reflects a…

Continue Reading

TuesdayDec 02, 2025 11:32 am

NetworkNewsBreaks – MAX Power Mining (CSE: MAXX) (OTC: MAXXF) (FRANKFURT: 89N) Featured in MiningNewsWire Editorial on Natural Hydrogen and AI-Era Energy Demand

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising.  MAX Power Mining (CSE: MAXX) (OTC: MAXXF) (FRANKFURT: 89N) said it was featured in a MiningNewsWire editorial titled “The Energy Breakthrough That Could Power the AI Era,” highlighting rising global electricity demand and the emerging potential of geologic natural hydrogen as a scalable low-carbon baseload energy source. The publication notes that the International Energy Agency expects global data center electricity use to nearly double by 2030, with AI centers increasing consumption more than four-fold. MAX Power, described as the first publicly traded North American…

Continue Reading

TuesdayDec 02, 2025 11:18 am

NetworkNewsBreaks – GlobalTech Corp. (OTC: GLTK) Agrees to Acquire 51% of Moda in Pelle to Expand AI-Driven Retail and UK Market Reach

  GlobalTech (OTC: GLTK), a U.S.-based technology holding company focused on AI, big data and emerging technologies, said it entered a definitive agreement to acquire a 51% interest in 123 Investments Limited d/b/a Moda in Pelle, a premium UK footwear brand with approximately $37 million in net revenue last year. The Company said the deal is expected to add a new revenue stream, strengthen its UK operational presence and enhance e-commerce capabilities through Thrivo AI integration, with closing expected within 30 days subject to customary conditions. CEO Dan Green said the acquisition aligns with GlobalTech’s value-creation strategy and will support…

Continue Reading

TuesdayDec 02, 2025 11:00 am

NetworkNewsBreaks – Stewards Inc. (OTC: SWRD) Appoints Scott McGowan Chief Marketing Officer 

  Stewards (OTC: SWRD), a diversified financial company operating across private credit, real assets and digital finance, appointed Scott McGowan as chief marketing officer to lead integrated marketing and communications as the Company expands its operating segments and advances toward a planned Nasdaq Capital Market uplisting. McGowan, formerly director of investor relations at InvestorBrandNetwork and previously CEO of a strategic communications consultancy, brings more than 20 years of experience advising growth-stage companies on brand positioning, capital-markets strategy and stakeholder engagement. President Shaun Quin said McGowan will strengthen transparency and unify messaging as Stewards enters its next phase of growth. To…

Continue Reading

TuesdayDec 02, 2025 9:50 am

NetworkNewsBreaks – HealthLynked Corp. (OTCQB: HLYK) Adds Insurance and Employer-Benefits Leaders Chris Pulos and Jason Bishara to Board

HealthLynked (OTCQB: HLYK), an AI-driven global healthcare network focused on improving care coordination and reducing costs, appointed Chris G. Pulos of Marsh McLennan Agency and Jason Bishara of NSI Insurance Group to its Board. The Company said the additions bring decades of experience in employer benefits, payer strategy, insurance and risk management as HealthLynked expands collaborations with insurers, employer groups and healthcare organizations. Founder and CEO Dr. Michael Dent said their expertise will support national scaling of the HealthLynked Network and its AI platform, ARI, while strengthening governance ahead of a planned Nasdaq Capital Market listing. To view the full…

Continue Reading

TuesdayDec 02, 2025 9:30 am

NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) JV Sapu Nano Presents Data Showing Deciparticle Platform Supports Broad Hydrophobic Drug Formulation

Oncotelic Therapeutics (OTCQB: OTLC) said its 45%-owned joint venture, Sapu Nano, reported new data at the 2025 San Antonio Breast Cancer Symposium showing that its Deciparticle(TM) nanomedicine platform can consistently formulate structurally diverse hydrophobic therapeutics—including macrolide mTOR inhibitors, cyclic and linear peptides, ascomycin macrolactams and polyketides—into sub-20 nm nanoparticles suitable for IV delivery. The Company said the findings confirm Deciparticle as a versatile, cGMP-ready delivery platform backed by ISO-5 manufacturing capabilities that support rapid translation to Phase 1 supply. CEO Dr. Vuong Trieu said the results position Deciparticle as a modular engine for multiple oncology, immunology and peptide drug candidates,…

Continue Reading